Cosentyx (secukinumab) is a medication that is used to treat various inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis (AS). Ankylosing spondylitis is a type of arthritis that affects the spine and other joints, causing pain and stiffness.

According to the official Cosentyx website [2], Cosentyx is approved by the FDA for the treatment of active ankylosing spondylitis in adults. The medication works by targeting and blocking a specific protein in the body called interleukin-17A (IL-17A), which is responsible for causing inflammation. By blocking this protein, Cosentyx can help reduce the symptoms of AS, including pain, stiffness, and swelling.

A study published in the Journal of Clinical Medicine Research [3] found that Cosentyx was effective in treating AS, with patients experiencing significant improvements in symptoms such as pain, stiffness, and fatigue. The study also found that Cosentyx was generally well-tolerated by patients, with few side effects reported.

However, as with any medication, there are potential side effects associated with Cosentyx. Common side effects include infections, such as upper respiratory tract infections, and injection site reactions, such as redness, swelling, or itching. In rare cases, more serious side effects such as allergic reactions or infections may occur [2].

In conclusion, Cosentyx is an FDA-approved medication that can be used to treat ankylosing spondylitis in adults. It works by blocking a specific protein in the body that causes inflammation, and has been shown to be effective in reducing symptoms such as pain and stiffness. However, as with any medication, there are potential side effects to be aware of. Patients should speak with their doctor to determine if Cosentyx is the right treatment option for them.

Sources:
[2] https://www.cosentyx.com/ankylosing-spondylitis/faq
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422944/
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX